Cambridge Advisors’s CVS Health CVS Stock Holding History

Cambridge Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,430	Closed	-$226K	–	182
2022 Q4	$226K	Sell	2,430 -13	-0.5%	-$1.25K	0.06%	170
2022 Q3	$233K	Sell	2,443 -149	-6%	-$14.7K	0.07%	157
2022 Q2	$240K	Sell	2,592 -149	-5%	-$14.5K	0.07%	158
2022 Q1	$277K	Buy	2,741 +13	+0.5%	+$1.37K	0.07%	155
2021 Q4	$281K	Buy	2,728 +14	+0.5%	+$1.29K	0.06%	159
2021 Q3	$230K	Buy	2,714 +5	+0.2%	+$419	0.06%	163
2021 Q2	$226K	Buy	+2,709	New	+$222K	0.05%	163

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cambridge Advisors's CVS Position: Q1 2023 in Review

Cambridge Advisors sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,430 shares — an estimated $226K sold.

Cambridge Advisors first reported a position in CVS in Q2 2021 and held it in 7 quarters. The position peaked at $281K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Cambridge Advisors reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Cambridge Advisors sold 2,430 CVS Health shares in Q1 2023, an estimated $226K.
Cambridge Advisors first reported a position in CVS Health in Q2 2021 and held it in 7 quarters.
Cambridge Advisors's CVS Health position peaked at $281K in Q4 2021.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Cambridge Advisors's 13F filing for Q1 2023, filed 13 Apr 2023.